Genomic Vision strengthens its management by welcoming Frédéric Hammel as Chief Operating Officer

24 January 2023 | Tuesday | News

GV, the "Company"), a biotechnology company listed on Euronext developing products and services dedicated to the analysis and control of genome modifications, announces the appointment of Frédéric Hammel as Chief Operating Officer, in order to strengthen its management.

Frédéric, a biologist by training (ENS, MBA from the College of Engineers), is a recognized leader, with more than 25 years of experience in the health sector. Prior to joining Genomic Vision, he was Managing Director of Ethera, a manufacturer of air quality analysis products. Prior to that, he was Chief Executive Officer of Platine Pharma Services SAS (a company that Bio Mérieux Group has since acquired), an analytical services company specializing in monitoring the immune response of patients in clinical trials (CRO), as well as TxCell, a biotechnology company developing cellular immunotherapies. At Genomic Vision, Frédéric will be in charge of managing all operational aspects of the company.

Frédéric HammelDirector of Operations at Genomic Vision, said: " I am very pleased to join the dynamic team of Genomic Visionwhich is committed to bringing excellence to its customers, especially in this momentum, where the robustness of the he technology opens up new application opportunities.»

Frédéric will be supported by the new Director of Human Resources, Claire Fleury, who has been involved in Human Resources for more than 20 years. With a Master's degree in Human and Social Sciences, completed with a Master's degree in Advanced Studies in Management, she will supervise the human resources of Genomic Vision.

Claire FleuryDirectorof Genomic Vision H umaines Resourcessays: "Joining Genomic vision means having the conviction that anything is possible, that resources are where we look and undertake. I am delighted to support the company's teams: expert, dynamic and positive teams are part of the deployment of innovative projects in the service of health. »

Aaron BensimonResident P CEOof Genomic Vision, said: "We are very pleased to welcome Claire and Frédéric to the Genomic Vision leadership team. They will help us build a strong business and provide exceptional genomic analysis solutions for our clients. Frédéric brings his knowledge in biotechnologyand his experience in the field of advanced therapies, a definite advantage for our teams. At the same time, we welcome Claire with great pleasure. It will play a critical role in supporting our workforce and enabling them to reach their full potential. »

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close